UB Paderborn / Katalog / Suche / in CDI

Biomedical informatics: development of a comprehensive data warehouse for clinical and genomic breast cancer research

Pharmacogenomics, 2004-10, Vol.5 (7), p.933-941

2004

Volltextzugriff (PDF)

Abstract P1-05-04: Novel breast cancer proteomic subtyping with connection to cell of origin

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-05-04

2022

Volltextzugriff (PDF)

Abstract 1188: Reclassification of ER+ (luminal A/luminal B1 minus ER low)-like and ER- like breast tumors based on proteomic/gene and clinical outcome signatures

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1188-1188

2021

Volltextzugriff (PDF)

Abstract 2342: Multidimensional metabolomic stratification of ER+/HER2- compared to ER-/HER2- breast tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2342-2342

2021

Volltextzugriff (PDF)

Abstract PS5-34: Identification of proteomics-based biomarkers for ER+/HER2- breast cancer stratification: Implications on clinical outcome

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS5-34-PS5-34

2021

Volltextzugriff (PDF)

Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group

The Journal of molecular diagnostics : JMD, 2013-01, Vol.15 (1), p.3-16

2013

Volltextzugriff (PDF)

Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests

The Journal of molecular diagnostics : JMD, 2023-03, Vol.25 (3), p.143-155

2023

Volltextzugriff (PDF)

Human Biospecimen Research: Experimental Protocol and Quality Control Tools

Cancer epidemiology, biomarkers & prevention, 2009-04, Vol.18 (4), p.1017-1025

2009

Volltextzugriff (PDF)

Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC)

Biopreservation and biobanking, 2012-08, Vol.10 (4), p.366

2012

Volltextzugriff (PDF)

Abstract P6-06-09: Evaluation of laser microdissected primary breast tumors for RNA Seq over bulk processing and validated with cohort control

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-06-09

2020

Volltextzugriff (PDF)

Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests: A Blood Profiling Atlas in Cancer (BLOODPAC) Community Study

The Journal of molecular diagnostics : JMD, 2023-03, Vol.25 (3), p.143-155

2023

Volltextzugriff (PDF)

Abstract 3402: Evaluation of laser microdissected primary breast tumors for RNA-Seq over bulk processing

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3402-3402

2019

Volltextzugriff (PDF)

Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

Cell reports. Medicine, 2022-11, Vol.3 (11), p.100819, Article 100819

2022

Volltextzugriff (PDF)

Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis

Clinical pharmacology and therapeutics, 2024-08

2024

Volltextzugriff (PDF)

Abstract 5660: Proteomic comparative assessment of flash-frozen and OCT embedded breast cancer tissues for utilization in precision oncology discovery studies

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5660-5660

2018

Volltextzugriff (PDF)

Abstract 284: Integrated proteogenomic analysis of laser microdissected primary breast tumors define proteome clusters

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.284-284

2018

Volltextzugriff (PDF)

HSPD1, HSPB1 and VDAC1 are Over-expressed in Invasive Ductal Carcinoma of the Breast

International journal of cancer research, 2016-03, Vol.12 (2), p.82-91

2016

Volltextzugriff (PDF)

Abstract 213: Integrated proteogenomic analysis of laser capture microdissected breast tumors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.213-213

2017

Volltextzugriff (PDF)

Abstract 3372: Differential exon usage in the HER2 subtype of breast cancer identified with RNA-seq and proteomic data

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3372-3372

2017

Volltextzugriff (PDF)

Abstract 4624: Differentiation of female donors classified as “normal”, with benign disease and with breast cancer based on blood RNA signature

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4624-4624

2010

Volltextzugriff (PDF)

Analysis of Matrix Metalloproteinase-1 Gene Polymorphisms and Expression in Benign and Malignant Breast Tumors

Cancer investigation, 2011-11, Vol.29 (9), p.599-607

2011

Volltextzugriff (PDF)

Preservation of Biospecimens at Ambient Temperature: Special Focus on Nucleic Acids and Opportunities for the Biobanking Community

Biopreservation and biobanking, 2016-04, Vol.14 (2), p.89

2016

Volltextzugriff (PDF)

Efficient Nonviral Cutaneous Transfection

Molecular therapy, 2000-08, Vol.2 (2), p.140-146

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Biomedical informatics: development of a comprehensive data warehouse for clinical and genomic breast cancer research

Abstract P1-05-04: Novel breast cancer proteomic subtyping with connection to cell of origin

Abstract 1188: Reclassification of ER+ (luminal A/luminal B1 minus ER low)-like and ER- like breast tumors based on proteomic/gene and clinical outcome signatures

Abstract 2342: Multidimensional metabolomic stratification of ER+/HER2- compared to ER-/HER2- breast tumors

Abstract PS5-34: Identification of proteomics-based biomarkers for ER+/HER2- breast cancer stratification: Implications on clinical outcome

Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group

Abstract 2172: Proteogenomics of laser microdissected difficult-to-treat breast cancers identifies Basal and Her2 patients associated with outcome differences

Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests

Human Biospecimen Research: Experimental Protocol and Quality Control Tools

Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC)

Abstract P6-06-09: Evaluation of laser microdissected primary breast tumors for RNA Seq over bulk processing and validated with cohort control

Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests: A Blood Profiling Atlas in Cancer (BLOODPAC) Community Study

Abstract 3402: Evaluation of laser microdissected primary breast tumors for RNA-Seq over bulk processing

Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis

Abstract 5660: Proteomic comparative assessment of flash-frozen and OCT embedded breast cancer tissues for utilization in precision oncology discovery studies

Abstract 284: Integrated proteogenomic analysis of laser microdissected primary breast tumors define proteome clusters

Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group

HSPD1, HSPB1 and VDAC1 are Over-expressed in Invasive Ductal Carcinoma of the Breast

Abstract 213: Integrated proteogenomic analysis of laser capture microdissected breast tumors

Abstract 3372: Differential exon usage in the HER2 subtype of breast cancer identified with RNA-seq and proteomic data

Abstract 4624: Differentiation of female donors classified as “normal”, with benign disease and with breast cancer based on blood RNA signature

Analysis of Matrix Metalloproteinase-1 Gene Polymorphisms and Expression in Benign and Malignant Breast Tumors

Preservation of Biospecimens at Ambient Temperature: Special Focus on Nucleic Acids and Opportunities for the Biobanking Community

Efficient Nonviral Cutaneous Transfection

Suchergebnisse filtern